Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2014

01.10.2014 | Original Article

Significance of Serum and Ascitic Fluid C-Reactive Protein in Differential Diagnosis of Benign and Malignant Ascites

verfasst von: Ilhami Yuksel, Fatih Karaahmet, Yusuf Coskun, Serta Kılıncalp, Mevlut Hamamci, Hakan Akinci, Yusuf Ustun, Zahide Simsek, Elife Erarslan, Sahin Coban

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The values of C-reactive protein (CRP) can prove useful in determining disease progress. Because of synthesis by the liver, production of CRP in response to inflammation may be attenuated in patients with liver dysfunction. This may result in differences interpreting CRP levels in patient with portal and non-portal hypertension ascites.

Aim

The aim of the present study is to assess discriminant value of serum and ascitic fluid CRP, which is easily accessible and inexpensive laboratory marker of inflammation, concentrations for diagnosis of underlying cause of ascites.

Methods

This prospective study was conducted at Dıskapı Yıldırım Beyazıt Educational and Research Hospital Department of Gastroenterology. Patients with ascites were further divided into two subgroups based on underlying cause of ascites: Group 1, patient with ascites due to portal hypertensive etiology (high-gradient ascites); Group 2, patient with ascites due to non-portal hypertensive etiology (low-gradient ascites).

Results

A total of 91 patients fulfilling the criteria for a diagnosis of ascites were enrolled in the study. Of these patients, 50 had proven (Group 1) ascites due to portal hypertensive etiology (high-gradient ascites) and 41 had clinical (Group 2) ascites due to non-portal hypertensive etiology (low-gradient ascites). Mean baseline serum and ascites levels of CRP were significantly higher in Group 2 compared to those in Group 1 (p = 0.021, p = <0.0001, respectively).

Conclusions

Increased levels of serum and ascitic fluid CRP were associated with malignant ascites.
Literatur
1.
Zurück zum Zitat Arroyo V. Pathophysiology, diagnosis and treatment of ascites in cirrhosis. Ann Hepatol. 2002;1:72–79.PubMed Arroyo V. Pathophysiology, diagnosis and treatment of ascites in cirrhosis. Ann Hepatol. 2002;1:72–79.PubMed
2.
Zurück zum Zitat Ginès P, Cárdenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med. 2004;350:1646–1654.PubMedCrossRef Ginès P, Cárdenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med. 2004;350:1646–1654.PubMedCrossRef
3.
Zurück zum Zitat Khan J, Pikkarainen P, Karvonen AL, et al. Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:970–974.PubMedCrossRef Khan J, Pikkarainen P, Karvonen AL, et al. Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:970–974.PubMedCrossRef
4.
Zurück zum Zitat Ginès P, Angeli P, Lenz K, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRef Ginès P, Angeli P, Lenz K, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRef
5.
Zurück zum Zitat Uddin MS, Hoque MI, Islam MB, et al. Serum–ascites albumin gradient in differential diagnosis of ascites. Mymensingh Med J. 2013;22:748–754.PubMed Uddin MS, Hoque MI, Islam MB, et al. Serum–ascites albumin gradient in differential diagnosis of ascites. Mymensingh Med J. 2013;22:748–754.PubMed
6.
Zurück zum Zitat Yang Y, Zhang W, Xu H, et al. A novel approach: transumbilical endoscopic exploration and biopsy for patients with unknown ascites. J Laparoendosc Adv Surg Tech A. 2012;22:691–694.PubMedCrossRef Yang Y, Zhang W, Xu H, et al. A novel approach: transumbilical endoscopic exploration and biopsy for patients with unknown ascites. J Laparoendosc Adv Surg Tech A. 2012;22:691–694.PubMedCrossRef
8.
Zurück zum Zitat Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–1653.PubMedCrossRef Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–1653.PubMedCrossRef
9.
Zurück zum Zitat Okino AM, Bürger C, Cardoso JR, et al. The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates. Mediat Inflamm. 2006;2006:47297.CrossRef Okino AM, Bürger C, Cardoso JR, et al. The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates. Mediat Inflamm. 2006;2006:47297.CrossRef
10.
Zurück zum Zitat Gotthardt DN, Weiss KH, Rathenberg V, et al. Persistent ascites after liver transplantation: etiology, treatment and impact on survival. Ann Transpl. 2013;18:378–383.CrossRef Gotthardt DN, Weiss KH, Rathenberg V, et al. Persistent ascites after liver transplantation: etiology, treatment and impact on survival. Ann Transpl. 2013;18:378–383.CrossRef
11.
Zurück zum Zitat Light RW. The light criteria: the beginning and why they are useful 40 years later. Clin Chest Med. 2013;34:21–26.PubMedCrossRef Light RW. The light criteria: the beginning and why they are useful 40 years later. Clin Chest Med. 2013;34:21–26.PubMedCrossRef
12.
Zurück zum Zitat Kuiper JJ, de Man RA, van Buuren HR. Review article: Management of ascites and associated complications in patients with cirrhosis. Aliment Pharmacol Ther. 2007;26:183–193.PubMedCrossRef Kuiper JJ, de Man RA, van Buuren HR. Review article: Management of ascites and associated complications in patients with cirrhosis. Aliment Pharmacol Ther. 2007;26:183–193.PubMedCrossRef
13.
Zurück zum Zitat Khandwalla HE, Fasakin Y, El-Serag HB. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis. Am J Gastroenterol. 2009;104:1401–1405.PubMedCrossRef Khandwalla HE, Fasakin Y, El-Serag HB. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis. Am J Gastroenterol. 2009;104:1401–1405.PubMedCrossRef
14.
Zurück zum Zitat Mansour-Ghanaei F, Shafaghi A, Bagherzadeh AH, et al. Low gradient ascites: a seven-year course review. World J Gastroenterol. 2005;11:2337–2339.PubMed Mansour-Ghanaei F, Shafaghi A, Bagherzadeh AH, et al. Low gradient ascites: a seven-year course review. World J Gastroenterol. 2005;11:2337–2339.PubMed
15.
Zurück zum Zitat Akriviadis EA, Kapnias D, Hadjigavriel M, et al. Serum/ascites albumin gradient: its value as a rational approach to the differential diagnosis of ascites. Scand J Gastroenterol. 1996;31:814–817.PubMedCrossRef Akriviadis EA, Kapnias D, Hadjigavriel M, et al. Serum/ascites albumin gradient: its value as a rational approach to the differential diagnosis of ascites. Scand J Gastroenterol. 1996;31:814–817.PubMedCrossRef
16.
Zurück zum Zitat Lu CW, Wang SS, Lee SD, et al. Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics. Zhonghua Yi Xue Za Zhi (Taipei). 1991;47:350–356. Lu CW, Wang SS, Lee SD, et al. Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics. Zhonghua Yi Xue Za Zhi (Taipei). 1991;47:350–356.
17.
Zurück zum Zitat Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61:824–833.PubMedCrossRefPubMedCentral Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61:824–833.PubMedCrossRefPubMedCentral
18.
Zurück zum Zitat Wang CS, Sun CF. C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. Chang Gung Med J. 2009;32:471–482.PubMed Wang CS, Sun CF. C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. Chang Gung Med J. 2009;32:471–482.PubMed
19.
Zurück zum Zitat Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7:193–199.CrossRef Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7:193–199.CrossRef
Metadaten
Titel
Significance of Serum and Ascitic Fluid C-Reactive Protein in Differential Diagnosis of Benign and Malignant Ascites
verfasst von
Ilhami Yuksel
Fatih Karaahmet
Yusuf Coskun
Serta Kılıncalp
Mevlut Hamamci
Hakan Akinci
Yusuf Ustun
Zahide Simsek
Elife Erarslan
Sahin Coban
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3205-4

Weitere Artikel der Ausgabe 10/2014

Digestive Diseases and Sciences 10/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.